Literature DB >> 19494269

The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals.

Koichi Yanaba1, Jean-David Bouaziz, Takashi Matsushita, Takeshi Tsubata, Thomas F Tedder.   

Abstract

Autoimmunity and inflammation are controlled in part by regulatory B cells, including a recently identified IL-10-competent CD1d(high)CD5(+) B cell subset termed B10 cells that represents 1-3% of adult mouse spleen B cells. In this study, pathways that influence B10 cell generation and IL-10 production were identified and compared with previously described regulatory B cells. IL-10-competent B cells were predominantly CD1d(high)CD5(+) in adult spleen and were the prevalent source of IL-10, but not other cytokines. B10 cell development and/or maturation in vivo required Ag receptor diversity and intact signaling pathways, but not T cells, gut-associated flora, or environmental pathogens. Spleen B10 cell frequencies were significantly expanded in aged mice and mice predisposed to autoimmunity, but were significantly decreased in mouse strains that are susceptible to exogenous autoantigen-induced autoimmunity. LPS, PMA, plus ionomycin stimulation in vitro for 5 h induced B10 cells to express cytoplasmic IL-10. However, prolonged LPS or CD40 stimulation (48 h) induced additional adult spleen CD1d(high)CD5(+) B cells to express IL-10 following PMA plus ionomycin stimulation. Prolonged LPS or CD40 stimulation of newborn spleen and adult blood or lymph node CD1d(low) and/or CD5(-) B cells also induced cytoplasmic IL-10 competence in rare B cells, with CD40 ligation uniformly inducing CD5 expression. IL-10 secretion was induced by LPS signaling through MyD88-dependent pathways, but not following CD40 ligation. LPS stimulation also induced rapid B10 cell clonal expansion when compared with other spleen B cells. Thereby, both adaptive and innate signals regulate B10 cell development, maturation, CD5 expression, and competence for IL-10 production.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494269      PMCID: PMC3733128          DOI: 10.4049/jimmunol.0900270

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

1.  CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes.

Authors:  Norihito Yazawa; Manabu Fujimoto; Shinichi Sato; Kensuke Miyake; Noriko Asano; Yoshinori Nagai; Osamu Takeuchi; Kiyoshi Takeda; Hitoshi Okochi; Shizuo Akira; Thomas F Tedder; Kunihiko Tamaki
Journal:  Blood       Date:  2003-04-24       Impact factor: 22.113

2.  Inhibitory coreceptors activated by antigens but not by anti-Ig heavy chain antibodies install requirement of costimulation through CD40 for survival and proliferation of B cells.

Authors:  Yasuhisa Hokazono; Takahiro Adachi; Matthias Wabl; Nobuhiko Tada; Teruo Amagasa; Takeshi Tsubata
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

3.  Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.

Authors:  J Tian; D Zekzer; L Hanssen; Y Lu; A Olcott; D L Kaufman
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

4.  Cutting Edge: Ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease.

Authors:  Tetsuya Higuchi; Yuichi Aiba; Takashi Nomura; Junichiro Matsuda; Keiji Mochida; Misao Suzuki; Hitoshi Kikutani; Tasuku Honjo; Kiyoshi Nishioka; Takeshi Tsubata
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

5.  Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses.

Authors:  Karen M Haas; Minoru Hasegawa; Douglas A Steeber; Jonathan C Poe; Mark D Zabel; Cheryl B Bock; David R Karp; David E Briles; John H Weis; Thomas F Tedder
Journal:  Immunity       Date:  2002-12       Impact factor: 31.745

Review 6.  CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction.

Authors:  J C Poe; M Hasegawa; T F Tedder
Journal:  Int Rev Immunol       Date:  2001       Impact factor: 5.311

7.  B cells regulate autoimmunity by provision of IL-10.

Authors:  Simon Fillatreau; Claire H Sweenie; Mandy J McGeachy; David Gray; Stephen M Anderton
Journal:  Nat Immunol       Date:  2002-09-03       Impact factor: 25.606

Review 8.  Interleukin-10 therapy--review of a new approach.

Authors:  K Asadullah; W Sterry; H D Volk
Journal:  Pharmacol Rev       Date:  2003-06       Impact factor: 25.468

9.  Severely impaired B lymphocyte proliferation, survival, and induction of the c-Myc:Cullin 1 ubiquitin ligase pathway resulting from CD22 deficiency on the C57BL/6 genetic background.

Authors:  Jonathan C Poe; Karen M Haas; Junji Uchida; Youngkyun Lee; Manabu Fujimoto; Thomas F Tedder
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

10.  Prevention of arthritis by interleukin 10-producing B cells.

Authors:  Claudia Mauri; David Gray; Naseem Mushtaq; Marco Londei
Journal:  J Exp Med       Date:  2003-02-17       Impact factor: 14.307

View more
  205 in total

1.  Pulsed high-dose dexamethasone improves interleukin 10 secretion by CD5+ B cells in patients with primary immune thrombocytopenia.

Authors:  Fanli Hua; Lili Ji; Yanxia Zhan; Feng Li; Shanhua Zou; Xiaoyun Wang; Dongli Song; Zhihui Min; Song Gao; Yangjiong Wu; Hao Chen; Yunfeng Cheng
Journal:  J Clin Immunol       Date:  2012-06-06       Impact factor: 8.317

2.  Regulatory B cells that produce IL-10: a breath of fresh air in allergic airway disease.

Authors:  Thomas F Tedder; Takashi Matsushita
Journal:  J Allergy Clin Immunol       Date:  2010-05       Impact factor: 10.793

3.  Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice.

Authors:  Mayuka Horikawa; Veronique Minard-Colin; Takashi Matsushita; Thomas F Tedder
Journal:  J Clin Invest       Date:  2011-10-24       Impact factor: 14.808

Review 4.  Regulatory B cells in autoimmunity: developments and controversies.

Authors:  Claudia Mauri; Paul A Blair
Journal:  Nat Rev Rheumatol       Date:  2010-09-21       Impact factor: 20.543

Review 5.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

6.  Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice.

Authors:  Sheng Xiao; Craig R Brooks; Chen Zhu; Chuan Wu; Johanna M Sweere; Sonia Petecka; Ada Yeste; Francisco J Quintana; Takaharu Ichimura; Raymond A Sobel; Joseph V Bonventre; Vijay K Kuchroo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-05       Impact factor: 11.205

7.  Gazing into a crystal ball to predict kidney transplant outcome.

Authors:  Bernd Schröppel; Peter S Heeger
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

Review 8.  The role of B-1 cells in inflammation.

Authors:  Monowar Aziz; Nichol E Holodick; Thomas L Rothstein; Ping Wang
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

9.  Innate profiles of cytokines implicated on oral tolerance correlate with low- or high-suppression of humoral response.

Authors:  Maria F Silva; Alice O Kamphorst; Elize A Hayashi; Maria Bellio; Claudia R Carvalho; Ana M C Faria; Kátia C C Sabino; Marsen G P Coelho; Alberto Nobrega; Daniel Tavares; Antonio C Silva
Journal:  Immunology       Date:  2010-03-16       Impact factor: 7.397

10.  IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model.

Authors:  Koichi Yanaba; Ayumi Yoshizaki; Yoshihide Asano; Takafumi Kadono; Thomas F Tedder; Shinichi Sato
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.